Humacyte Correlations

HUMAW Stock  USD 0.13  0.02  18.18%   
The current 90-days correlation between Humacyte and Arcturus Therapeutics Holdings is 0.17 (i.e., Average diversification). The correlation of Humacyte is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Humacyte Correlation With Market

Excellent diversification

The correlation between Humacyte and DJI is -0.68 (i.e., Excellent diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Humacyte and DJI in the same portfolio, assuming nothing else is changed.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Humacyte. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For more information on how to buy Humacyte Stock please use our How to Invest in Humacyte guide.

Moving together with Humacyte Stock

  0.61DRMA Dermata TherapeuticsPairCorr
  0.62ABNX Abionyx Pharma SAPairCorr
  0.7DTIL Precision BioSciencesPairCorr

Moving against Humacyte Stock

  0.74VERA Vera TherapeuticsPairCorr
  0.67DRUG Bright Minds BiosciencesPairCorr
  0.6EQ EquilliumPairCorr
  0.53DSGN Design TherapeuticsPairCorr
  0.51DRTS Alpha Tau MedicalPairCorr
  0.48GXEA Galapagos NV Earnings Call This WeekPairCorr
  0.44DXB Dimerix Earnings Call This WeekPairCorr
  0.39DMAC DiaMedica TherapeuticsPairCorr
  0.31SAB Sonic HealthcarePairCorr
  0.78NP5 NEWRON PHARMACEUTPairCorr
  0.74HDP1 Arrowhead PharmaceuticalsPairCorr
  0.7VNDA Vanda Pharmaceuticals Downward RallyPairCorr
  0.63VTVT vTv TherapeuticsPairCorr
  0.61VRTX Vertex PharmaceuticalsPairCorr
  0.590P6S Bayer AG NAPairCorr
  0.49KTTAW Pasithea TherapeuticsPairCorr
  0.38DVAX Dynavax TechnologiesPairCorr

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

TNYAPYXS
ASMBIMRX
PYXSASMB
FHTXZURA
SGMTPYXS
TNYAASMB
  

High negative correlations

ASMBZURA
PYXSZURA
PYXSFHTX
TNYAZURA
FHTXASMB
TNYAFHTX

Risk-Adjusted Indicators

There is a big difference between Humacyte Stock performing well and Humacyte Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Humacyte's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
ABEO  2.47  0.20  0.07  0.19  2.91 
 5.53 
 12.04 
IMRX  3.92 (0.01)(0.01)(4.74) 8.39 
 8.98 
 67.18 
ZURA  3.53  0.70  0.14  0.80  4.24 
 9.32 
 33.15 
ASMB  3.02 (0.47) 0.00 (0.33) 0.00 
 5.85 
 18.53 
FHTX  3.62  0.52  0.11 (0.34) 3.34 
 8.60 
 31.12 
PYXS  6.02 (1.16) 0.00 (0.69) 0.00 
 11.68 
 66.31 
TNYA  4.82 (1.05) 0.00 (0.26) 0.00 
 9.02 
 48.07 
NAUT  4.49  0.83  0.15 (4.66) 4.29 
 9.85 
 28.35 
SGMT  3.08 (0.51) 0.00 (0.61) 0.00 
 5.78 
 22.02 
ARCT  2.88 (0.03) 0.01  0.04  3.49 
 6.53 
 15.98 

Humacyte Corporate Management

MS MSChief OfficerProfile
Dale SanderChief CFOProfile
Heather ConnellySenior QualityProfile
William ScheesseleChief OfficerProfile
Lisa MolyneuxExecutive AnalysisProfile
Shamik MDChief OfficerProfile